Isabel Amador-Martínez

5PUBLICATIONS
17CO-AUTHORS
Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 14, 2025
Effect of N-Acetylcysteine in Mitochondrial Function, Redox Signaling, and Sirtuin 3 Levels in the Heart During Cardiorenal Syndrome Type 4 Development.

Isabel Amador-Martínez, Omar Emiliano Aparicio-Trejo, Ana Karina Aranda-Rivera

|Apr 14, 2025
Sulforaphane Restores Mitochondrial β-Oxidation and Reduces Renal Lipid Accumulation in a Model of Releasing Unilateral Ureteral Obstruction.

Ana Karina Aranda-Rivera, Isabel Amador-Martínez, Omar Emiliano Aparicio-Trejo

|Nov 14, 2023
Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4.

Isabel Amador-Martínez, Omar Emiliano Aparicio-Trejo, Bismarck Bernabe-Yepes

|Mar 11, 2023
The Development of Dyslipidemia in Chronic Kidney Disease and Associated Cardiovascular Damage, and the Protective Effects of Curcuminoids.

Zeltzin Alejandra Ceja-Galicia, Ana Karina Aranda-Rivera, Isabel Amador-Martínez

|Oct 27, 2022
Sulforaphane Protects against Unilateral Ureteral Obstruction-Induced Renal Damage in Rats by Alleviating Mitochondrial and Lipid Metabolism Impairment.

Ana Karina Aranda-Rivera, Alfredo Cruz-Gregorio, Omar Emiliano Aparicio-Trejo

Pageof 1

Frequent Collaborators

5 joint publications

Ana Karina Aranda-Rivera

5 joint publications

José Pedraza-Chaverri

3 joint publications

Omar Emiliano Aparicio-Trejo

2 joint publications

Alfredo Cruz-Gregorio